Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo-Reference-Cited by-同舟云学术

Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo

Published:2017-09 Issue: Volume:145 Page:33-43
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Yuan Shuofeng,Chan Jasper Fuk-Woo,den-Haan Helena^ORCID,Chik Kenn Ka-Heng,Zhang Anna Jinxia,Chan Chris Chung-Sing,Poon Vincent Kwok-Man,Yip Cyril Chik-Yan,Mak Winger Wing-Nga,Zhu Zheng,Zou Zijiao,Tee Kah-Meng,Cai Jian-Piao,Chan Kwok-Hung,de la Peña Jorge,Pérez-Sánchez Horacio,Cerón-Carrasco José Pedro,Yuen Kwok-Yung

Funder

Hui Hoy and Chow Sin Lan Charity Fund Limited

Consultancy Service for Enhancing Laboratory Surveillance of Emerging Infectious Diseases of the Department of Health

Hong Kong Special Administrative Region

Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases

Ministry of Education of China

Fundación Séneca del Centro de Coordinación de la Investigación de la Región de Murcia

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference47 articles.